scaling method Search Results


kcas bio analytical  (KCAS Bioanalytical and Biomarker Services)
99
KCAS Bioanalytical and Biomarker Services kcas bio analytical
Kcas Bio Analytical, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kcas bio analytical/product/KCAS Bioanalytical and Biomarker Services
Average 99 stars, based on 1 article reviews
kcas bio analytical - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
corn starch extraction method  (Small Scale Industries)
90
Small Scale Industries corn starch extraction method
Corn Starch Extraction Method, supplied by Small Scale Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/corn starch extraction method/product/Small Scale Industries
Average 90 stars, based on 1 article reviews
corn starch extraction method - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scaling method  (OpenSim Ltd)
90
OpenSim Ltd scaling method
Scaling Method, supplied by OpenSim Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scaling method/product/OpenSim Ltd
Average 90 stars, based on 1 article reviews
scaling method - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
system usability scale (sus) method  (Hydrofarm Inc)
90
Hydrofarm Inc system usability scale (sus) method
System Usability Scale (Sus) Method, supplied by Hydrofarm Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/system usability scale (sus) method/product/Hydrofarm Inc
Average 90 stars, based on 1 article reviews
system usability scale (sus) method - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
isovist analysis method  (Small Scale Industries)
90
Small Scale Industries isovist analysis method
Isovist Analysis Method, supplied by Small Scale Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/isovist analysis method/product/Small Scale Industries
Average 90 stars, based on 1 article reviews
isovist analysis method - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
msd approach  (Meso Scale Diagnostics LLC)
90
Meso Scale Diagnostics LLC msd approach
Impact of AL002c treatment on <t>total</t> <t>Aβ</t> load. (A) Quantification of methoxy-X04 + area coverage in the cortex (Ctx) and hippocampus (HC) of treated mice. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. (B) Volume of individual methoxy-X04 + Aβ plaques in the cortex of indicated treatment groups. The volume of ∼1,000 plaques per condition was determined by Imaris. (C–F) PBS-soluble and PBS-insoluble guanidine-soluble fractions of hippocampus were assessed for Aβ 1–40 (C and E) and Aβ 1–42 (D and F) by <t>MSD.</t> Values for PBS-soluble Aβ 1–40 were below the limit of detection in some samples. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. No differences were detected for Aβ 1–40 or Aβ 1–42 in PBS-insoluble guanidine-soluble fractions of cortices among treatment groups (not depicted). PBS-soluble fractions of cortices showed no detectable Aβ 1–40 or Aβ 1–42 by MSD . *, P < 0.05; **, P < 0.01 by two-way ANOVA. Data are presented as mean ± SEM.
Msd Approach, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/msd approach/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
msd approach - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scale and master ball artefact (samba) method  (GE Baker Hughes)
90
GE Baker Hughes scale and master ball artefact (samba) method
Impact of AL002c treatment on <t>total</t> <t>Aβ</t> load. (A) Quantification of methoxy-X04 + area coverage in the cortex (Ctx) and hippocampus (HC) of treated mice. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. (B) Volume of individual methoxy-X04 + Aβ plaques in the cortex of indicated treatment groups. The volume of ∼1,000 plaques per condition was determined by Imaris. (C–F) PBS-soluble and PBS-insoluble guanidine-soluble fractions of hippocampus were assessed for Aβ 1–40 (C and E) and Aβ 1–42 (D and F) by <t>MSD.</t> Values for PBS-soluble Aβ 1–40 were below the limit of detection in some samples. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. No differences were detected for Aβ 1–40 or Aβ 1–42 in PBS-insoluble guanidine-soluble fractions of cortices among treatment groups (not depicted). PBS-soluble fractions of cortices showed no detectable Aβ 1–40 or Aβ 1–42 by MSD . *, P < 0.05; **, P < 0.01 by two-way ANOVA. Data are presented as mean ± SEM.
Scale And Master Ball Artefact (Samba) Method, supplied by GE Baker Hughes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scale and master ball artefact (samba) method/product/GE Baker Hughes
Average 90 stars, based on 1 article reviews
scale and master ball artefact (samba) method - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
and microscale device fabrication methods using split structures and alignment elements  (Meso Scale Diagnostics LLC)
90
Meso Scale Diagnostics LLC and microscale device fabrication methods using split structures and alignment elements
Impact of AL002c treatment on <t>total</t> <t>Aβ</t> load. (A) Quantification of methoxy-X04 + area coverage in the cortex (Ctx) and hippocampus (HC) of treated mice. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. (B) Volume of individual methoxy-X04 + Aβ plaques in the cortex of indicated treatment groups. The volume of ∼1,000 plaques per condition was determined by Imaris. (C–F) PBS-soluble and PBS-insoluble guanidine-soluble fractions of hippocampus were assessed for Aβ 1–40 (C and E) and Aβ 1–42 (D and F) by <t>MSD.</t> Values for PBS-soluble Aβ 1–40 were below the limit of detection in some samples. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. No differences were detected for Aβ 1–40 or Aβ 1–42 in PBS-insoluble guanidine-soluble fractions of cortices among treatment groups (not depicted). PBS-soluble fractions of cortices showed no detectable Aβ 1–40 or Aβ 1–42 by MSD . *, P < 0.05; **, P < 0.01 by two-way ANOVA. Data are presented as mean ± SEM.
And Microscale Device Fabrication Methods Using Split Structures And Alignment Elements, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/and microscale device fabrication methods using split structures and alignment elements/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
and microscale device fabrication methods using split structures and alignment elements - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
exploratory eclia method  (Meso Scale Diagnostics LLC)
90
Meso Scale Diagnostics LLC exploratory eclia method
Impact of AL002c treatment on <t>total</t> <t>Aβ</t> load. (A) Quantification of methoxy-X04 + area coverage in the cortex (Ctx) and hippocampus (HC) of treated mice. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. (B) Volume of individual methoxy-X04 + Aβ plaques in the cortex of indicated treatment groups. The volume of ∼1,000 plaques per condition was determined by Imaris. (C–F) PBS-soluble and PBS-insoluble guanidine-soluble fractions of hippocampus were assessed for Aβ 1–40 (C and E) and Aβ 1–42 (D and F) by <t>MSD.</t> Values for PBS-soluble Aβ 1–40 were below the limit of detection in some samples. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. No differences were detected for Aβ 1–40 or Aβ 1–42 in PBS-insoluble guanidine-soluble fractions of cortices among treatment groups (not depicted). PBS-soluble fractions of cortices showed no detectable Aβ 1–40 or Aβ 1–42 by MSD . *, P < 0.05; **, P < 0.01 by two-way ANOVA. Data are presented as mean ± SEM.
Exploratory Eclia Method, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exploratory eclia method/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
exploratory eclia method - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ssgblup method  (Small Scale Industries)
90
Small Scale Industries ssgblup method
Impact of AL002c treatment on <t>total</t> <t>Aβ</t> load. (A) Quantification of methoxy-X04 + area coverage in the cortex (Ctx) and hippocampus (HC) of treated mice. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. (B) Volume of individual methoxy-X04 + Aβ plaques in the cortex of indicated treatment groups. The volume of ∼1,000 plaques per condition was determined by Imaris. (C–F) PBS-soluble and PBS-insoluble guanidine-soluble fractions of hippocampus were assessed for Aβ 1–40 (C and E) and Aβ 1–42 (D and F) by <t>MSD.</t> Values for PBS-soluble Aβ 1–40 were below the limit of detection in some samples. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. No differences were detected for Aβ 1–40 or Aβ 1–42 in PBS-insoluble guanidine-soluble fractions of cortices among treatment groups (not depicted). PBS-soluble fractions of cortices showed no detectable Aβ 1–40 or Aβ 1–42 by MSD . *, P < 0.05; **, P < 0.01 by two-way ANOVA. Data are presented as mean ± SEM.
Ssgblup Method, supplied by Small Scale Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ssgblup method/product/Small Scale Industries
Average 90 stars, based on 1 article reviews
ssgblup method - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
methodical mind software  (Meso Scale Diagnostics LLC)
90
Meso Scale Diagnostics LLC methodical mind software
Impact of AL002c treatment on <t>total</t> <t>Aβ</t> load. (A) Quantification of methoxy-X04 + area coverage in the cortex (Ctx) and hippocampus (HC) of treated mice. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. (B) Volume of individual methoxy-X04 + Aβ plaques in the cortex of indicated treatment groups. The volume of ∼1,000 plaques per condition was determined by Imaris. (C–F) PBS-soluble and PBS-insoluble guanidine-soluble fractions of hippocampus were assessed for Aβ 1–40 (C and E) and Aβ 1–42 (D and F) by <t>MSD.</t> Values for PBS-soluble Aβ 1–40 were below the limit of detection in some samples. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. No differences were detected for Aβ 1–40 or Aβ 1–42 in PBS-insoluble guanidine-soluble fractions of cortices among treatment groups (not depicted). PBS-soluble fractions of cortices showed no detectable Aβ 1–40 or Aβ 1–42 by MSD . *, P < 0.05; **, P < 0.01 by two-way ANOVA. Data are presented as mean ± SEM.
Methodical Mind Software, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/methodical mind software/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
methodical mind software - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
wafer-scale surface micromachining method for pdms  (Verlag GmbH)
90
Verlag GmbH wafer-scale surface micromachining method for pdms
Impact of AL002c treatment on <t>total</t> <t>Aβ</t> load. (A) Quantification of methoxy-X04 + area coverage in the cortex (Ctx) and hippocampus (HC) of treated mice. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. (B) Volume of individual methoxy-X04 + Aβ plaques in the cortex of indicated treatment groups. The volume of ∼1,000 plaques per condition was determined by Imaris. (C–F) PBS-soluble and PBS-insoluble guanidine-soluble fractions of hippocampus were assessed for Aβ 1–40 (C and E) and Aβ 1–42 (D and F) by <t>MSD.</t> Values for PBS-soluble Aβ 1–40 were below the limit of detection in some samples. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. No differences were detected for Aβ 1–40 or Aβ 1–42 in PBS-insoluble guanidine-soluble fractions of cortices among treatment groups (not depicted). PBS-soluble fractions of cortices showed no detectable Aβ 1–40 or Aβ 1–42 by MSD . *, P < 0.05; **, P < 0.01 by two-way ANOVA. Data are presented as mean ± SEM.
Wafer Scale Surface Micromachining Method For Pdms, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wafer-scale surface micromachining method for pdms/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
wafer-scale surface micromachining method for pdms - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Impact of AL002c treatment on total Aβ load. (A) Quantification of methoxy-X04 + area coverage in the cortex (Ctx) and hippocampus (HC) of treated mice. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. (B) Volume of individual methoxy-X04 + Aβ plaques in the cortex of indicated treatment groups. The volume of ∼1,000 plaques per condition was determined by Imaris. (C–F) PBS-soluble and PBS-insoluble guanidine-soluble fractions of hippocampus were assessed for Aβ 1–40 (C and E) and Aβ 1–42 (D and F) by MSD. Values for PBS-soluble Aβ 1–40 were below the limit of detection in some samples. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. No differences were detected for Aβ 1–40 or Aβ 1–42 in PBS-insoluble guanidine-soluble fractions of cortices among treatment groups (not depicted). PBS-soluble fractions of cortices showed no detectable Aβ 1–40 or Aβ 1–42 by MSD . *, P < 0.05; **, P < 0.01 by two-way ANOVA. Data are presented as mean ± SEM.

Journal: The Journal of Experimental Medicine

Article Title: Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model

doi: 10.1084/jem.20200785

Figure Lengend Snippet: Impact of AL002c treatment on total Aβ load. (A) Quantification of methoxy-X04 + area coverage in the cortex (Ctx) and hippocampus (HC) of treated mice. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. (B) Volume of individual methoxy-X04 + Aβ plaques in the cortex of indicated treatment groups. The volume of ∼1,000 plaques per condition was determined by Imaris. (C–F) PBS-soluble and PBS-insoluble guanidine-soluble fractions of hippocampus were assessed for Aβ 1–40 (C and E) and Aβ 1–42 (D and F) by MSD. Values for PBS-soluble Aβ 1–40 were below the limit of detection in some samples. Each CV-KO-5XFAD treatment group, n = 7; each R47H-KO-5XFAD treatment group, n = 6. No differences were detected for Aβ 1–40 or Aβ 1–42 in PBS-insoluble guanidine-soluble fractions of cortices among treatment groups (not depicted). PBS-soluble fractions of cortices showed no detectable Aβ 1–40 or Aβ 1–42 by MSD . *, P < 0.05; **, P < 0.01 by two-way ANOVA. Data are presented as mean ± SEM.

Article Snippet: Aβ 1–40 and Aβ 1–42 levels were measured in both fractions by the Meso Scale Discovery (MSD) approach.

Techniques: